N. Jewel Samadder

1. Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
   2020/09/09 by Carol A. Burke, Evelien Dekker, Patrick M. Lynch +28 · 1 citation
   Medicine · Biochemistry, Genetics and Molecular Biology · #Genetic factors in colorectal cancer #Inflammatory mediators and NSAID effects #Connective tissue disorders research #Sulindac #Eflornithine #Medicine #Familial adenomatous polyposis #Hazard ratio #Gastroenterology #Chemoprophylaxis #Internal medicine #Adenomatous polyposis coli #Surgery #Colorectal cancer #Confidence interval #Cancer
2. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial
   2016/08/01 by Carol A. Burke, Evelien Dekker, N. Jewel Samadder +2 · 1 citation
   Biochemistry, Genetics and Molecular Biology · Medicine · #Polyamine Metabolism and Applications #Microbial metabolism and enzyme function #Glycosylation and Glycoproteins Research #Sulindac #Familial adenomatous polyposis #Medicine #Eflornithine #Gastroenterology #Internal medicine #Clinical endpoint #Colorectal cancer #Placebo #Randomized controlled trial #Chemoprophylaxis #Adenomatous polyposis coli #Adverse effect #Cancer #Ornithine decarboxylase #Pathology
3. Serrated Polyposis
   2013/10/07 by Kory Jasperson, Kory W. Jasperson, Priyanka Kanth +7 · 10 citations
   Medicine · #Abdominal surgery #Colorectal Cancer Screening and Detection #Colorectal surgery #Gastric Cancer Management and Outcomes #General surgery #Genetic factors in colorectal cancer #Medicine #Surgery #Surgical oncology